Rafferty Asset Management
CATX icon

Rafferty Asset Management’s Perspective Therapeutics CATX Stock Holding History

Rafferty Asset Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Buy
112,194
+19,382
+21% +$73.2K ﹤0.01% 960
2026
Q1 		$387K Buy
+92,812
New +$392K ﹤0.01% 928
2024
Q4 		– Sell
-101,138
Closed -$1.35M – 1145
2024
Q3 		$1.35M Buy
+101,138
New +$1.35M ﹤0.01% 728

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Rafferty Asset Management's CATX Position: Q2 2026 in Review

Rafferty Asset Management increased its Perspective Therapeutics (CATX) stake by 21% in Q2 2026, buying an estimated $73.2K and bringing the position to 112,194 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #960.

Rafferty Asset Management first reported a position in CATX in Q3 2024 and has held it in 3 quarters since. The position peaked at $1.35M in Q3 2024. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Rafferty Asset Management held 112,194 shares of Perspective Therapeutics worth $383K as of Q2 2026.
  • Rafferty Asset Management bought 19,382 Perspective Therapeutics shares in Q2 2026, an estimated $73.2K.
  • Perspective Therapeutics made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #960 holding.
  • Rafferty Asset Management first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Rafferty Asset Management's Perspective Therapeutics position peaked at $1.35M in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.